VI
AZN icon

VectorGlobal IAG’s AstraZeneca AZN Stock Holding History

VectorGlobal IAG’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$822K Buy
+4,245
New +$819K 0.21% 65

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

VectorGlobal IAG's AZN Position: Q1 2026 in Review

VectorGlobal IAG opened a new position in AstraZeneca (AZN) in Q1 2026: 4,245 shares worth $822K. The stake represents 0.21% of the portfolio and ranks #65 among its holdings.

1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • VectorGlobal IAG held 4,245 shares of AstraZeneca worth $822K as of Q1 2026.
  • AstraZeneca was a new VectorGlobal IAG position in Q1 2026.
  • AstraZeneca made up 0.21% of VectorGlobal IAG's portfolio in Q1 2026, its #65 holding.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on VectorGlobal IAG's 13F filing for Q1 2026, filed 30 Jun 2026.